Federal contract award

75N91023C00042

ARPA-H SBIR PHASE II TOPIC ARPA-H 04 INTRA-OPERATIVE CONTRAST AGENTS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeFIRM FIXED PRICE
Obligations$4.2M
Current contract value$4.2M
Potential contract value / ceiling$4.2M
Start dateSep 15, 2023
Current end dateSep 14, 2027
Potential end dateSep 14, 2027
Latest award activityJul 16, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 16, 2025P00005$0THE PURPOSE OF THIS MODIFICATION IS TO: A. CHANGE THE CONTRACTING OFFICE FROM NIH NCI TO ARPA-H B. UPDATE BUYER AND CONTRACTING OFFICER INFORMATION C. UPDATE IPP INVOICING INSTRUCTIONS D. UPDATE THE COR INFORMATION FROM JENICA PATTERSON TO MICHE
Apr 30, 2025P00004$0ARPA-H SBIR PHASE II TOPIC ARPA-H 04 INTRA-OPERATIVE CONTRAST AGENTS
Mar 25, 2025P00003$0THE PURPOSE OF THIS MODIFICATION IS TO: 1) ADD SAMUEL GUSSMANTOH AS ALTERNATE COR AND 2) CHANGE THE CENTRAL POINT OF DISTRIBUTION.
Sep 10, 2024P00002$3.6MTHE PURPOSE OF THIS MODIFICATION IS TO: 1) EXERCISE OPTION 1 FOR SBIR PHASE II; 2) OBLIGATE FY 2024 FUNDS TO FULLY FUND THE THREE-YEAR SBIR PHASE II IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF THE FIRM FIXED PRICE, NON-SEVERABLE SERVICES CONTRACT;
Jul 12, 2024P00001$45.1KPURPOSE: 1) CHANGE COR DESIGNATION AND 2) IN SCOPE CHANGE TO STATEMENT OF WORK.
Sep 15, 20230$599.2KARPA-H SBIR PHASE II TOPIC ARPA-H 04 INTRA-OPERATIVE CONTRAST AGENTS

Estimated positioning window

Oct 25, 2026 – Mar 14, 2027

Recompete signal:
75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2027-09-14 (324 days from calculation)
+35 points
16 historical awards in this buyer and category group
+15 points
6 recorded award transactions
+10 points
Latest award action: 2025-07-16
+0 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Mary MuirContactmary.muir@nih.gov
2402766533
SourceJun 27, 2023
Mary MuirContactmary.muir@nih.gov
2402766533
SourceJun 22, 2023
Mary MuirContactmary.muir@nih.gov
2402766533
SourceJun 16, 2023
Mary MuirContactmary.muir@nih.gov
2402766533
SourceJun 12, 2023
Mary MuirContactmary.muir@nih.gov
2402766533
SourceJun 12, 2023
Mary MuirContactmary.muir@nih.gov
2402766533
SourceJun 2, 2023

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.